文献速递骨质疏松与代谢性骨病创伤骨科

2型糖尿病中老年人群骨肌减少症的患病率、危险因素及不良健康结局:范围综述

Prevalence, risk factors and adverse health outcomes of osteosarcopenia in middle-aged and older adults with type 2 diabetes mellitus-a scoping review.
PubMed 文献 · Osteoporos Int · 2026-10-03

该范围综述纳入9项研究(7项横断面、2项病例对照),总结2型糖尿病≥40岁成人中骨肌减少症(OS)的患病率、危险因素、生物标志物及不良结局。尽管OS定义异质性大,OS在T2D中普遍存在;β细胞功能差、低BMI和小腰围与OS风险升高相关,骨钙素可能是潜在生物标志物,OS可能与跌倒和腿部骨折相关。

要点

  • T2D中老年人群OS普遍存在,但定义异质性大。
  • β细胞功能差、低BMI和小腰围与OS风险升高相关。
  • 骨钙素可能是OS潜在生物标志物,OS或与跌倒和腿部骨折相关。

核心结论

  • 本范围综述发现T2D中OS相关信息匮乏,需纵向研究全面表型分析以填补知识空白。

主要发现

  • 尽管OS定义存在显著异质性,OS在T2D中普遍存在。
  • T2D患者中β细胞功能差、低体重指数和小腰围者OS风险增加。
  • 胰岛素抵抗、T2D病程、血糖控制及二甲双胍、磺脲类和胰岛素使用未显示为显著危险因素。
  • 骨钙素是T2D中OS的潜在有用生物标志物,OS可能与T2D患者跌倒和腿部骨折相关。

临床怎么用

  • 对T2D中老年患者,尤其β细胞功能差、低BMI或小腰围者,应关注OS风险。
  • 骨钙素或可作为T2D患者OS的潜在生物标志物供临床参考。
  • T2D合并OS患者需警惕跌倒和腿部骨折风险。

局限性

  • 纳入研究数量少(9项研究),OS定义异质性大,缺乏纵向研究,信息匮乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Osteoporosis and sarcopenia are increasingly recognised as important complications of type 2 diabetes mellitus (T2D). As both conditions share common pathophysiological mechanisms, they can coexist in the same individual. The coexistence of osteoporosis and sarcopenia, known as osteosarcopenia (OS), is an emerging geriatric syndrome. Compared with its individual components, OS has received much less attention. The overall objective of this scoping review was to summarise the existing literature on the prevalence, risk factors, biomarkers, and adverse health outcomes associated with OS in adults with T2D aged ≥ 40. A search was conducted in eight online databases (Ovid MEDLINE®, Embase (Ovid), PubMed, CINAHL, Cochrane Library, Web of Science, Scopus and PsycINFO) and grey literature sources for relevant articles published in English up to 31 July 2024. A total of ten articles reporting findings from nine distinct studies (7 cross-sectional, 2 case-control) were included. Despite significant heterogeneity in its definition, OS was shown to be prevalent in T2D. The risk of OS was increased in individuals with T2D who had poor β-cell function, low body mass index, and smaller waist circumference. Insulin resistance, duration of T2D, glycaemic control, and metformin, sulfonylurea and insulin use were not shown to be significant risk factors. Osteocalcin was a potentially useful biomarker of OS in T2D, and OS may be associated with falls and leg fractures in T2D. In conclusion, this scoping review revealed a paucity of information about OS in T2D. Longitudinal studies with comprehensive phenotyping are required to address the many knowledge gaps.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Tan AWK, Wong CS, Smith HE, et al. Prevalence, risk factors and adverse health outcomes of osteosarcopenia in middle-aged and older adults with type 2 diabetes mellitus-a scoping review. Osteoporos Int. 2026. PMID: 42828564. doi:10.1007/s00198-026-08228-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。